First Time Loading...

SIGA Technologies Inc
NASDAQ:SIGA

Watchlist Manager
SIGA Technologies Inc Logo
SIGA Technologies Inc
NASDAQ:SIGA
Watchlist
Price: 8.56 USD 0.71% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. [ Read More ]

The intrinsic value of one SIGA stock under the Base Case scenario is 12.91 USD. Compared to the current market price of 8.56 USD, SIGA Technologies Inc is Undervalued by 34%.

Key Points:
SIGA Intrinsic Value
Base Case
12.91 USD
Undervaluation 34%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
SIGA Technologies Inc

Backtest SIGA Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SIGA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of SIGA Technologies Inc's business.

What risks and challenges
does SIGA Technologies Inc face in the near future?

Summarize the latest earnings report
of SIGA Technologies Inc.

Provide P/E
for SIGA Technologies Inc and its competitors.

Financials

Balance Sheet Decomposition
SIGA Technologies Inc

Current Assets 239m
Cash & Short-Term Investments 150.1m
Receivables 21.1m
Other Current Assets 67.7m
Non-Current Assets 15.4m
PP&E 1.3m
Intangibles 898.3k
Other Non-Current Assets 13.1m
Current Liabilities 54.1m
Accounts Payable 1.5m
Accrued Liabilities 7.5m
Other Current Liabilities 45.1m
Non-Current Liabilities 3.4m
Other Non-Current Liabilities 3.4m
Efficiency

Earnings Waterfall
SIGA Technologies Inc

Revenue
139.9m USD
Cost of Revenue
-17.2m USD
Gross Profit
122.7m USD
Operating Expenses
-38.5m USD
Operating Income
84.2m USD
Other Expenses
-16.2m USD
Net Income
68.1m USD

Free Cash Flow Analysis
SIGA Technologies Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

SIGA Profitability Score
Profitability Due Diligence

SIGA Technologies Inc's profitability score is 80/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Exceptional 3-Year Average ROE
Positive Gross Profit
80/100
Profitability
Score

SIGA Technologies Inc's profitability score is 80/100. The higher the profitability score, the more profitable the company is.

SIGA Solvency Score
Solvency Due Diligence

SIGA Technologies Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

SIGA Technologies Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SIGA Price Targets Summary
SIGA Technologies Inc

Wall Street analysts forecast SIGA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SIGA is 17.88 USD with a low forecast of 17.71 USD and a high forecast of 18.41 USD.

Lowest
Price Target
17.71 USD
107% Upside
Average
Price Target
17.88 USD
109% Upside
Highest
Price Target
18.41 USD
115% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SIGA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SIGA Price
SIGA Technologies Inc

1M 1M
+64%
6M 6M
+63%
1Y 1Y
+62%
3Y 3Y
+52%
5Y 5Y
+64%
10Y 10Y
+218%
Annual Price Range
8.56
52w Low
4.32
52w High
8.56
Price Metrics
Average Annual Return 8.48%
Standard Deviation of Annual Returns 30.05%
Max Drawdown -82%
Shares Statistics
Market Capitalization 608.5m USD
Shares Outstanding 71 091 600
Percentage of Shares Shorted 11.19%

SIGA Return Decomposition
Main factors of price return

What is price return decomposition?

SIGA News

Other Videos

Last Important Events
SIGA Technologies Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
SIGA Technologies Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

SIGA Technologies Inc Logo
SIGA Technologies Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

608.5m USD

Dividend Yield

0%

Description

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company is headquartered in New York City, New York and currently employs 39 full-time employees. The Company’s lead product, TPOXX (oral TPOXX), is an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The firm does not have a manufacturing infrastructure and does not intend to develop one for the manufacture of TPOXX. The company uses contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company’s CMOs apply methods and controls in facilities, which are uses for manufacturing, processing, packaging, testing, analyzing and holding pharmaceuticals, which conform to current good manufacturing practices (cGMP), the standard set by the FDA for manufacture and storage of pharmaceuticals intended for human use. For the manufacture of oral TPOXX, the Company uses the four CMOs, namely W.R. Grace and Company; Powdersize, LLC; Catalent Pharma Solutions LLC, and Packaging Coordinators, LLC.

Contact

NEW YORK
New York City
31 E 62nd St
+12126729100.0
https://www.siga.com/

IPO

1997-09-09

Employees

39

Officers

Executive VP, CFO & Secretary
Mr. Daniel J. Luckshire
Executive VP & Chief Scientific Officer
Dr. Dennis E. Hruby
Executive VP, Chief Medical Officer & Director
Dr. Jay K. Varma M.D.
CEO & Director
Dr. Diem Nguyen M.B.A., Ph.D.
Senior VP of Operations & Chief Supply Chain Officer
Ms. Tove C. Bolken
Senior VP & Chief Information Officer
Mr. Herb Vloedman

See Also

Discover More
What is the Intrinsic Value of one SIGA stock?

The intrinsic value of one SIGA stock under the Base Case scenario is 12.91 USD.

Is SIGA stock undervalued or overvalued?

Compared to the current market price of 8.56 USD, SIGA Technologies Inc is Undervalued by 34%.